Strategy

Achieving federated analysis through partnership, by Philip Quinlan

Read more

MicroRNA as a source of drugs for obesity, Interview with Resalis Therapeutics

Read more

Obesity Review, New drugs and new indications in the clinic, by Peter Charlish

Read more

European biopharma forecasts for 2024

Read more

Caszyme pioneers gene editing from Lithuania

Read more

Zealand Pharma maps out strategy for obesity

Read more

The weight loss sector continues to evolve

Read more

Unlocking value in pharma R&D

Read more

Raising the threshold: argenx predicts continued market expansion

Read more

Provincialism holds back Europe's biotech sector

Read more